Sodium-glucose cotransporter 2 inhibitors (SGLT2i) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: SGLT2 inhibitors

Filter by location:

Philadelphia, Pennsylvania1 trial

Transformative Research in Diabetic Nephropathy 2.0

Penn Presbyterian Medical Center

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.